Skip to main content
. 2019 Oct 11;3(12):2295–2304. doi: 10.1210/js.2019-00305

Table 3.

Immunotherapy-Related Adverse Events

Any Grade Adverse Events That Occurred in ≥2 Patients N (%)
Fatigue 4 (66.7)
Pruritis 2 (33.3)
Rash 3 (50)
Decreased appetite 2 (33.3)
Headaches 2 (33.3)
Neuropathy 2 (33.3)
Dyspnea (pneumonitis ruled out) 2 (33.3)
Nausea 4 (66.7)
Diarrhea (colitis ruled out) 3 (50)
Rectal bleeding 2 (33.3)
Dehydration 2 (33.3)
Grade ≥3 adverse events that occurred in ≥1 patient N, (%)
Hepatitis (grade 3) 1 (16.7)
Nausea (grade 3) 1 (16.7)
Mouth sores (grade 3) 1 (16.7)
Diarrhea (colitis ruled out) (grade 3) 1 (16.7)
Adverse events of special interest
Focal pneumonitis (grade 2) 1 (16.7)